Enfermedades Sistémicas de Base Autoinmune

Axis 1: Biological and targeted therapies for rheumatic diseases

L1: Safety and efficacy in biologic and targeted therapies -BIOBADASER

L2: Biomarkers of response to methotrexate and JAK inhibitors.

Axis 2: Rheumatoid arthritis

L1: Early arthritis - REUCARE

Axis 3: Systemic autoimmune rheumatic diseases

L1: FAST track in giant cell arteritis

L2: Biomarkers of activity in scleroderma

L3: Remission and discordance in SLE - RELESSER

L4: Characterisation of Sjogren's syndrome

Axis 4: Osteoporosis and Bone Metabolism

L1: Osteoporosis and mastocytosis

Axis 5: Imaging in rheumatology

L1: Ultrasonography in large vessel vasculitis

Axis 6: Chronic musculoskeletal pain

L1. Fibromyalgia and COVID19